In this study, we found that both VPA and WT161 could reduce the expression of APP, β-secretase (BACE1) and γ-secretase (PSEN1), and WT161 could partially restore the expression of α-secretase (ADAM10) in the AD cell model (Fig. 2). Here, BACE1 is linked to Alzheimer disease.